摘要
目的确定合适方案筛查出脑卒中高危人群,评价脑安胶囊对其干预的效果。方法选取2011年3月~2012年3月在本医院就诊的2584例患者为研究对象,应用CVHI积分为指标对其进行脑卒中高危因素筛查。筛选出脑卒中高危人群在患者知情自愿的情况下分为脑安胶囊干预组274例和对照干预组264例。干预方案实施后随访2年,通过血压、CVHI积分值及脑卒中发病率的比较来评价干预后的效果。结果脑安胶囊干预组患者接受干预方案后疗效显著,收缩压、舒张压均低于对照干预组;CVHI积分值显著高于对照干预组(P〈0.05)。脑安胶囊干预后患者脑卒中发生率显著降低(P〈0.05)。结论脑安胶囊能显著改善脑血管功能,对降低脑卒中发生率具有良好效果。
Objective To screen out the suitable scheme to set stroke risk groups,evaluate Naoan capsule on the intervention effect for it. Methods 2584 patients from March 2011 to March 2012 in our hospital were selected as the research object,CVHI score was used as an index for screening high risk factors for stroke.Stroke risk groups under the condition of the patients with voluntary were selected and divided into Naoan capsule intervention group (274 cases) and controlled intervention group ( 264 cases).Followed up for 2 years after the intervention approach,CVHI score values and the incidence of stroke were compared to evaluate the effect after the intervention through blood pressure. Resuits The curative effect of patients in Naoan capsule intervention group after accepted intervention plan were distinct, the systolic pressure,diastolic pressure were lower than the controlled intervention group.CVHI score value was significandy higher than controlled intervention group (P〈0.05).Brain stroke incidence of patients after Naoan capsule intervention decreased significantly (P〈0.05). Conclusion Naoan capsule can significantly improve vascular function,and has a good effect to reduce the incidence of stroke.
出处
《中国当代医药》
2014年第19期47-49,共3页
China Modern Medicine
关键词
脑卒中高危人群
筛查
脑安胶囊
干预效果评价
Stroke risk groups
Screening
Naoan capsule
Intervention effect evaluation